ConductScience.org, home

Paper41253147

Gene therapy for hemoglobinopathies: Clinical trial results and biology of hematopoietic stem cell and the bone marrow niche.

Aprile A and 2 others. Cell Rep Med, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Gene therapy for hemoglobinopathies: Clinical trial results and biology of hematopoietic stem cell and the bone marrow niche. Papers, record 41253147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41253147

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Gene therapy for hemoglobinopathies: Clinical trial results and biology of hematopoietic stem cell and the bone marrow niche.
PubMed
Journal
Cell Rep Med
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-01-08
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aprile AAnnamaria
2Lidonnici MRMaria Rosa
3Ferrari GGiuliana

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genetic TherapyMajor topic
Hematopoietic Stem CellsMajor topic
HemoglobinopathiesMajor topic
Bone MarrowMajor topic
Stem Cell NicheMajor topic
Humans
Gene Editing
Clinical Trials as Topic
Animals
Anemia, Sickle Cell

Source PubMed

Download CSV of topics

References109

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118245381Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18245381PubMed
233283989CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.N Engl J Med2021https://conductscience.org/library/papers/33283989PubMed
337646679CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease.N Engl J Med2023https://conductscience.org/library/papers/37646679PubMed
440592819Imbalanced TGFβ signalling and autophagy drive erythroid priming of hematopoietic stem cells in β-thalassemia.Nat Commun2025https://conductscience.org/library/papers/40592819PubMed
532396618Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease.Blood Adv2020https://conductscience.org/library/papers/32396618PubMed
635073399Unique molecular and functional features of extramedullary hematopoietic stem and progenitor cell reservoirs in humans.Blood2022https://conductscience.org/library/papers/35073399PubMed
736161320Lovo-cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB-206 study.Am J Hematol2023https://conductscience.org/library/papers/36161320PubMed
814574413Osteoblastic cells regulate the haematopoietic stem cell niche.Nature2003https://conductscience.org/library/papers/14574413PubMed
919056937Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A.Science2008https://conductscience.org/library/papers/19056937PubMed
1035858618Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging.Cell Stem Cell2022https://conductscience.org/library/papers/35858618PubMed
1139293082UM171 enhances fitness and engraftment of gene-modified hematopoietic stem cells from patients with sickle cell disease.Blood Adv2024https://conductscience.org/library/papers/39293082PubMed
1225957113Microarchitectural and mechanical characterization of the sickle bone.J Mech Behav Biomed Mater2015https://conductscience.org/library/papers/25957113PubMed
1319474450A novel human gamma-globin gene vector for genetic correction of sickle cell anemia in a humanized sickle mouse model: critical determinants for successful correction.Blood2009https://conductscience.org/library/papers/19474450PubMed
1428830890Increased risk of leukemia among sickle cell disease patients in California.Blood2017https://conductscience.org/library/papers/28830890PubMed
1533956057Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease.Blood Adv2021https://conductscience.org/library/papers/33956057PubMed
1612639987Spontaneous circulation of myeloid-lymphoid-initiating cells and SCID-repopulating cells in sickle cell crisis.J Clin Invest2003https://conductscience.org/library/papers/12639987PubMed
1736333351Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression.Nat Commun2022https://conductscience.org/library/papers/36333351PubMed
1831279229In Vivo Outcome of Homology-Directed Repair at the HBB Gene in HSC Using Alternative Donor Template Delivery Methods.Mol Ther Nucleic Acids2019https://conductscience.org/library/papers/31279229PubMed
199734950Granulocytosis causing sickle-cell crisis.Lancet1998https://conductscience.org/library/papers/9734950PubMed
2040419809Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trial.Nat Med2025https://conductscience.org/library/papers/40419809PubMed

See all 109 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42074029Clinical Trial Landscape of Gene-Edited Autologous Hematopoietic Stem Cells for Hemoglobinopathies and Immunodeficiencies.Int J Mol Sci2026https://conductscience.org/library/papers/42074029PubMed
41753067Curative Approach to the Treatment of Beta-Thalassemia and Sickle Cell Disease with Hematopoietic Stem Cell Transplantation.J Clin Med2026https://conductscience.org/library/papers/41753067PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41253147

GET https://conductscience.org/api/papers/v1/41253147/references?page=2